Neuropilin-2

Neuropilin-2

Neuropilin-2 Informations sur la molécule

Molecule Name
Neuropilin 2
Alias de la molécule
Neuropilin-2,NRP2,VEGF165R2,Neuropilin2,Vascular endothelial cell growth factor 165 receptor 2
Drug Development Progress
Nombre de médicaments cliniques1
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 3 Clinical
Alias de la cible
Neuropilin-2,Vascular endothelial cell growth factor 165 receptor 2,NPN2,NP2,Neuropilin-2a(22),Neuropilin-2b(0),VEGF165R2,PRO2714,Neuropilin-2a(17),Receptor For VEGF165 And Semaphorins Class3
Contexte de la molécule
Neuropilin-1 (Npn-1, previously known as neuropilin) and Neuropilin-2 (previously known as Npn-1-related molecule) are type I transmembrane proteins that bind distinct members of the class III secreted semaphorin subfamily that are implicated in repulsive axon guidance. Neuropilin extracellular domains contain two CUB (complement-binding) domains, two domains with homology to coagulation factors V and VIII, and a MAM (meprin) domain. In the absence of ligands, neuropilins can form homo- and hetero-oligomers via their MAM domains. Expression in developing neurons of the central and peripheral nervous systems is somewhat overlapping but distinct. Npn-1 and Npn-2 are also receptors for VEGF165 on endothelial and tumor cells.

Neuropilin-2 Liste de produits

Species
  • Human(2)
Tag
  • His Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(2)
Conjugate
  • Biotin-labeled(1)
  • Unconjugated(1)
Grade
  • RUO(2)
Low Endotoxin
  • No(2)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
Neuropilin-2
Human Neuropilin-2 / NRP2 Protein, His Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPR

$390.00

100ug
Neuropilin-2
Avitag
NR2-H82E3
Biotinylated Human Neuropilin-2 / NRP2 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$368.00

25ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
EfzofitimodATYR-1923; KRP-R120Phase 3 ClinicalAtyr Pharma
Coronavirus Disease 2019 (COVID-19); Lung Diseases, Interstitial; Sarcoidosis, Pulmonary
Details
Customer Reviews